New class of Antibiotics disrupts protein synthesis

Odilorhabdins:

Odilorhabdins, or ODLs, a new class of antibiotics which disrupts protein synthesis are produced by symbiotic bacteria Xenorhabdus Nematophilia, found in soil-dwelling nematode worms that colonize insects for food. The bacteria Xenorhabdus Nematophilia actually helps to kill the insect and, importantly, secrete the antibiotic to keep competating the other bacteria away. Till now, these nematode-associated bacteria and the antibiotics they make have been largely understudied. To identify the antibiotic property present in the xenorhabdus bacteria, researchers screened 80 cultured strains of the bacteria & isolated the active compounds showing properties of antibiotics, studied their chemical structures and engineered more potent derivatives. ODLs mainly act on the ribosome, which is the molecular machine of individual cells that makes the proteins it needs to function of bacterial cells.

Like many clinically useful antibiotics, ODLs work by targeting the ribosome, but ODLs are unique because they bind to a place on the ribosome that has never been used by other known antibiotics. The ODLs when binds to the ribosome, the antibiotic disrupts its ability to interpret and translate genetic code. When ODLs are introduced to the bacterial cells, they impact the reading ability of the ribosome and cause the ribosome to make mistakes when it creates new proteins. This miscoding corrupts the cell with flawed proteins and causes the bacterial cell death. Many antibiotics can slow bacterial growth, but the antibiotics that actually kill bacteria, called bactericidal antibiotics, are rare. The bactericidal mechanism of ODLs and the fact that they bind to a site on the ribosome not exploited by any known antibiotic are very strong indicators that it has the potential to treat infections that are unresponsive to other antibiotics.

Now-a-days WHO is also focusing on antibiotic resistant, which is one of the gigantic threats to global health today and a significant contributor to longer hospital stays, higher medical costs and increased mortality? The researchers, academics & pharma industries have been collaborated with each other , which is needed to combat the growing and global threat of antibiotic resistance. Currently, pharma professionals, microbiologists & academia are working together for this.

Article written by:

Utkalendu suvendusekhar samantaray

MSc Biotechnology

Utkal University

Comments

Novel Nano-vaccines for Melanoma /skin Cancer

Researchers have developed a novel Nano-vaccine for melanoma, the most aggressive type of skin cancer that begins in melanocytes. Their experiments have proven effective in preventing the development of melanoma and in treating primary tumours and metastases that result from melanoma. The focus of the research was on a nanoparticle that serves as the basis for the new vaccine. Melanoma develops in the skin cells, which is called the melanocytes, produce melanin or skin pigment. The fight against skin cancer/melanoma is becoming advanced over the years through a variety of treatment modalities & experiments, such as immunotherapy, radiation therapy & chemotherapy, but the vaccine approach, which has a great effect against various viral diseases, has not materialized yet against cancer. Scientists have shown that it is possible to produce an effective Nano-vaccine against melanoma/skin cancer and to sensitize the immune system to immunotherapies. The researchers harnessed ...

Choosing biotechnology as a career? Post COVID- 19 challenges

Biotech careers: Choosing biotechnology as a career can be the best option for life science job aspirants to build a better career in the future. Biotechnology can additionally grow your career as well as your vision towards your goal. If you are a job aspirant in the life science field, you normally search for laboratory and academic careers, which are quite disappointing nowadays becaus e of the tough exams like NET and GATE. After even qualifying the exam it is getting difficult to get a fellowship in a recognized university or in a research center for further growth in your career. From my experiences, I would recommend shifting your go al towards com mercial division like the pharmaceuticals , agricultural products, animal farming, probiotics, diary, transgenic crops , transgenic animals, etc. Practical experiences matter a lot rather than your qualification and theoretica l knowledge. You might have heard about the industrial biotechnology and experimental biotechnology that is...

Can Microorganisms Be A Solution To The World's Energy Problems?

Can Microorganisms Be A Solution To The World's Energy Problems? Microorganisms once had an empire on the Earth, thriving by filling every nook and cranny of the environment billions of years before humans first arrived on the scene. The ability of microorganisms to grow from any infinite variety of food sources, rocks, soil, inside roots, compost piles & toxic waste etc. may play a significant role in bailing out our society from the current energy crisis. The Bio design researchers have outlined the paths, where bacteria are the best hope in producing renewable energy in large quantities without damaging the environment or competing with our food supply. Two distinct, but complementary uses of bacteria, which is a current major challenging research area, are: (1)The first use of the microbes is to convert biomass to useful energy. Different microorganisms can grow without oxygen to take this abundant organic matter and convert it to useful forms of energy such as m...

Biotech_Facts

Search This Blog